| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 7.32e-10 | 37 | 170 | 8 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 9.20e-10 | 38 | 170 | 8 | GO:0070001 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | ROCK2 FLNB IQGAP2 MYO6 MYO7B KIF1B CAPN2 JAKMIP3 NEB GSK3B GSN SPAG5 IQGAP1 MYO5C FMNL3 MSRB2 LLGL2 KIF3B LLGL1 ALMS1 PTPRN ARHGEF7 FMN1 NFKB1 MARK4 WDR1 TOR1AIP1 NOS3 CAP2 | 5.08e-08 | 1099 | 170 | 29 | GO:0008092 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.60e-06 | 11 | 170 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 4.75e-06 | 14 | 170 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 CAPN2 CASP8 CASP10 ERVK-7 ERVK-21 ERVK-9 ERVK-10 USP16 ADAMDEC1 ERVK-8 C1S ERVK-19 ERVK-24 | 1.97e-05 | 430 | 170 | 14 | GO:0004175 |
| GeneOntologyMolecularFunction | actin filament binding | 2.57e-05 | 227 | 170 | 10 | GO:0051015 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 2.71e-05 | 21 | 170 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | peptidase activity | CYLD ERVK-6 CAPN2 CASP8 CASP10 ERVK-7 ERVK-21 ERVK-9 ERVK-10 USP16 ADAMDEC1 OTUD6B UFD1 ERVK-8 C1S ERVK-19 ERVK-24 | 4.51e-05 | 654 | 170 | 17 | GO:0008233 |
| GeneOntologyMolecularFunction | GTPase binding | ROCK2 DMXL2 PLK2 IQGAP2 POU4F1 IQGAP1 FMNL3 KIF3B LLGL1 PTPRN ARHGEF7 SRGAP1 | 6.27e-05 | 360 | 170 | 12 | GO:0051020 |
| GeneOntologyMolecularFunction | actin binding | FLNB IQGAP2 MYO6 MYO7B NEB GSN IQGAP1 MYO5C FMNL3 MSRB2 FMN1 WDR1 NOS3 CAP2 | 6.36e-05 | 479 | 170 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | myosin II binding | 1.63e-04 | 13 | 170 | 3 | GO:0045159 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 2.69e-04 | 37 | 170 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 2.99e-04 | 38 | 170 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | ribosomal small subunit binding | 3.78e-04 | 17 | 170 | 3 | GO:0043024 | |
| GeneOntologyMolecularFunction | death effector domain binding | 4.28e-04 | 4 | 170 | 2 | GO:0035877 | |
| GeneOntologyMolecularFunction | structural molecule activity | SHANK1 ROCK2 NPHP1 ERVK-6 COL11A2 COL12A1 ERVK-7 ERVK-21 ERVK-9 ERVK-10 NEB LLGL1 ERVK-8 ERVK-5 ERVK-19 CRYBG3 ERVK-24 TNXB | 6.08e-04 | 891 | 170 | 18 | GO:0005198 |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 6.26e-04 | 46 | 170 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | cadherin binding | 6.73e-04 | 339 | 170 | 10 | GO:0045296 | |
| GeneOntologyMolecularFunction | dolichyl-diphosphooligosaccharide-protein glycotransferase activity | 7.09e-04 | 5 | 170 | 2 | GO:0004579 | |
| GeneOntologyMolecularFunction | oligosaccharyl transferase activity | 7.09e-04 | 5 | 170 | 2 | GO:0004576 | |
| GeneOntologyMolecularFunction | tau-protein kinase activity | 8.29e-04 | 22 | 170 | 3 | GO:0050321 | |
| GeneOntologyMolecularFunction | 3'-5' RNA helicase activity | 1.06e-03 | 6 | 170 | 2 | GO:0034458 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | IPPK ROCK2 ERVK-6 PLK2 PDGFRL GRK6 SCYL1 ERVK-7 ERVK-10 LMTK3 YES1 GSK3B TGFBR2 GUCY2D MARK4 ERVK-8 TJP2 ALPK2 | 1.10e-03 | 938 | 170 | 18 | GO:0016772 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | 1.31e-03 | 192 | 170 | 7 | GO:0008234 | |
| GeneOntologyMolecularFunction | enzyme activator activity | ROCK2 IQGAP2 CASP8 PPP1R15A TBC1D17 IQGAP1 TGFBR2 ARHGAP5 PPP2R5A LLGL2 LLGL1 UBE2N SH3PXD2A SRGAP1 | 1.49e-03 | 656 | 170 | 14 | GO:0008047 |
| GeneOntologyMolecularFunction | zinc ion binding | CYLD ERVK-6 RARG ERVK-7 ERVK-21 ERVK-9 ERVK-10 USP16 LIN28A MSRB2 ADAMDEC1 ZNF589 ERVK-8 ERVK-5 ERVK-19 ZCCHC7 ERVK-24 | 1.60e-03 | 891 | 170 | 17 | GO:0008270 |
| GeneOntologyMolecularFunction | small GTPase binding | 1.76e-03 | 321 | 170 | 9 | GO:0031267 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | CNTN4 FLNB RSL1D1 SCYL1 LARP1 EXOC3 CDH23 GSK3B IQGAP1 TJP1 TJP2 TNXB NOS3 | 1.90e-03 | 599 | 170 | 13 | GO:0050839 |
| GeneOntologyMolecularFunction | calcium ion binding | EFCAB5 DCHS2 RASGRP4 EFCAB6 PCDHGB7 PCDHGB6 FAT3 CAPN2 CDH23 GSN IQGAP1 FAT1 PPP2R3A C1S PLA2G4F | 1.90e-03 | 749 | 170 | 15 | GO:0005509 |
| GeneOntologyMolecularFunction | ATP-dependent activity | DHX16 ATP8B3 MYO6 MYO7B SMC1A KIF1B DHX38 TRIP13 MYO5C KIF3B ABCB11 AQR TDRD12 | 2.35e-03 | 614 | 170 | 13 | GO:0140657 |
| GeneOntologyBiologicalProcess | cell-cell fusion | ERVK-6 RIPOR2 CAPN2 ERVK-21 ERVK-9 GSK3B SH3PXD2A ERVK-8 ERVK-19 | 3.78e-08 | 85 | 172 | 9 | GO:0140253 |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | ERVK-6 RIPOR2 CAPN2 ERVK-21 ERVK-9 GSK3B SH3PXD2A ERVK-8 ERVK-19 | 3.78e-08 | 85 | 172 | 9 | GO:0000768 |
| GeneOntologyBiologicalProcess | syncytium formation | ERVK-6 RIPOR2 CAPN2 ERVK-21 ERVK-9 GSK3B SH3PXD2A ERVK-8 ERVK-19 | 5.67e-08 | 89 | 172 | 9 | GO:0006949 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | SHANK1 ROCK2 NPHP1 FLNB IQGAP2 MYO6 MYO7B NEB GSN IQGAP1 MYO5C FMNL3 MSRB2 FAT1 LLGL2 LLGL1 ALMS1 TJP1 ARHGEF7 FMN1 WDR1 GRHL3 TNXB CAP2 | 6.01e-08 | 803 | 172 | 24 | GO:0030036 |
| GeneOntologyBiologicalProcess | actin filament-based process | SHANK1 ROCK2 NPHP1 FLNB IQGAP2 MYO6 MYO7B NEB GSN IQGAP1 MYO5C FMNL3 MSRB2 FAT1 LLGL2 LLGL1 ALMS1 TJP1 ARHGEF7 FMN1 SCN8A WDR1 GRHL3 TNXB CAP2 | 1.62e-07 | 912 | 172 | 25 | GO:0030029 |
| GeneOntologyBiologicalProcess | cortical cytoskeleton organization | 4.62e-07 | 57 | 172 | 7 | GO:0030865 | |
| GeneOntologyBiologicalProcess | cortical actin cytoskeleton organization | 1.92e-06 | 45 | 172 | 6 | GO:0030866 | |
| GeneOntologyBiologicalProcess | DNA integration | 3.15e-06 | 13 | 172 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | regulation of establishment or maintenance of cell polarity | 4.58e-06 | 30 | 172 | 5 | GO:0032878 | |
| GeneOntologyBiologicalProcess | actin filament organization | SHANK1 ROCK2 IQGAP2 MYO6 MYO7B NEB GSN IQGAP1 MYO5C MSRB2 FAT1 ALMS1 TJP1 FMN1 WDR1 CAP2 | 5.94e-06 | 509 | 172 | 16 | GO:0007015 |
| GeneOntologyBiologicalProcess | sensory perception of sound | RIPOR2 COL11A2 MYO6 MYO7B CDH23 ALMS1 TJP1 SCARB2 SCN8A WDR1 | 6.59e-06 | 198 | 172 | 10 | GO:0007605 |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | ROCK2 RIPOR2 GSK3B GSN SPAG5 FAT1 LLGL2 LLGL1 WDR1 ALPK2 CAP2 | 1.09e-05 | 257 | 172 | 11 | GO:0007163 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | ROCK2 ERVK-6 MYF6 PLK2 SDK2 RIPOR2 COL12A1 RARG FAT3 CAPN2 ISM1 CASP8 ERVK-21 ERVK-9 PPP1R15A NEB PTGIS GSK3B FMNL3 TGFBR2 PPP2R3A TJP1 SH3PXD2A FMN1 ERVK-8 ERVK-19 WDR1 GRHL3 NOS3 | 1.44e-05 | 1483 | 172 | 29 | GO:0048646 |
| GeneOntologyBiologicalProcess | establishment of cell polarity | 1.82e-05 | 177 | 172 | 9 | GO:0030010 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | SHANK1 ROCK2 CYLD RIPOR2 IQGAP2 CAPN2 NEB GSK3B GSN SPAG5 ALMS1 TJP1 ARHGEF7 FMN1 WDR1 GRHL3 | 2.90e-05 | 579 | 172 | 16 | GO:0051493 |
| GeneOntologyBiologicalProcess | negative regulation of dephosphorylation | 3.18e-05 | 44 | 172 | 5 | GO:0035305 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | RIPOR2 COL11A2 MYO6 MYO7B CDH23 ALMS1 TJP1 SCARB2 SCN8A WDR1 | 3.24e-05 | 238 | 172 | 10 | GO:0050954 |
| GeneOntologyBiologicalProcess | viral process | ZNF502 ERVK-6 LARP1 ERVK-7 ERVK-21 ERVK-9 ERVK-10 GSK3B GSN SCARB2 ERVK-8 ERVK-5 ERVK-19 ERVK-24 | 3.63e-05 | 464 | 172 | 14 | GO:0016032 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | SHANK1 ROCK2 COL11A2 COL12A1 IQGAP2 MYO6 MYO7B NEB GSN IQGAP1 MYO5C MSRB2 CCDC13 FAT1 ALMS1 TJP1 ARHGEF7 FMN1 WDR1 TNXB CAP2 | 4.99e-05 | 957 | 172 | 21 | GO:0097435 |
| GeneOntologyBiologicalProcess | regulation of dephosphorylation | 1.01e-04 | 128 | 172 | 7 | GO:0035303 | |
| GeneOntologyBiologicalProcess | negative regulation of phosphatase activity | 1.08e-04 | 30 | 172 | 4 | GO:0010923 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | SDK2 RIPOR2 RARG MYO6 FAT3 NAGLU CDH23 FAT1 PPP2R3A ALMS1 GRHL3 | 1.49e-04 | 343 | 172 | 11 | GO:0090596 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 1.79e-04 | 187 | 172 | 8 | GO:0007156 | |
| GeneOntologyBiologicalProcess | assembly of actomyosin apparatus involved in mitotic cytokinesis | 2.06e-04 | 3 | 172 | 2 | GO:1902407 | |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly | 2.06e-04 | 3 | 172 | 2 | GO:1903475 | |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly actin filament organization | 2.06e-04 | 3 | 172 | 2 | GO:1903479 | |
| GeneOntologyBiologicalProcess | morphogenesis of a polarized epithelium | 3.61e-04 | 73 | 172 | 5 | GO:0001738 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly actin filament organization | 4.10e-04 | 4 | 172 | 2 | GO:2000689 | |
| GeneOntologyCellularComponent | actin cytoskeleton | SHLD2 FLNB IQGAP2 MYO6 MYO7B CAPN2 NEB YES1 GSN IQGAP1 MYO5C LLGL2 LLGL1 TJP1 SH3PXD2A FMN1 WDR1 | 7.32e-06 | 576 | 175 | 17 | GO:0015629 |
| GeneOntologyCellularComponent | cell cortex | FLNB IQGAP2 MYO6 CAPN2 EXOC3 GSN IQGAP1 LLGL2 LLGL1 ARHGEF7 WDR1 SEPTIN10 | 7.17e-05 | 371 | 175 | 12 | GO:0005938 |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 1.32e-04 | 93 | 175 | 6 | GO:0030864 | |
| GeneOntologyCellularComponent | basal ectoplasmic specialization | 2.08e-04 | 3 | 175 | 2 | GO:0061832 | |
| GeneOntologyCellularComponent | podosome | 3.77e-04 | 41 | 175 | 4 | GO:0002102 | |
| GeneOntologyCellularComponent | KICSTOR complex | 4.14e-04 | 4 | 175 | 2 | GO:0140007 | |
| GeneOntologyCellularComponent | anchoring junction | NPHP1 FLNB DCHS2 CAPN2 YES1 GSN IQGAP1 KIAA1210 FAT1 LLGL2 LLGL1 TJP1 ARHGEF7 SH3PXD2A FMN1 SCARB2 TJP2 ABCB11 WDR1 | 5.53e-04 | 976 | 175 | 19 | GO:0070161 |
| GeneOntologyCellularComponent | cortical cytoskeleton | 7.68e-04 | 129 | 175 | 6 | GO:0030863 | |
| GeneOntologyCellularComponent | cochlear hair cell ribbon synapse | 1.02e-03 | 6 | 175 | 2 | GO:0098683 | |
| GeneOntologyCellularComponent | ripoptosome | 1.02e-03 | 6 | 175 | 2 | GO:0097342 | |
| HumanPheno | Hepatocellular carcinoma | 1.47e-05 | 75 | 56 | 7 | HP:0001402 | |
| Domain | SH3 | SHANK1 NPHP1 MYO7B NEB YES1 TJP1 ARHGEF7 SH3PXD2A SRGAP1 NGEF TJP2 | 3.56e-06 | 216 | 165 | 11 | SM00326 |
| Domain | SH3 | SHANK1 NPHP1 MYO7B NEB YES1 TJP1 ARHGEF7 SH3PXD2A SRGAP1 NGEF TJP2 | 3.56e-06 | 216 | 165 | 11 | PS50002 |
| Domain | SH3_domain | SHANK1 NPHP1 MYO7B NEB YES1 TJP1 ARHGEF7 SH3PXD2A SRGAP1 NGEF TJP2 | 4.25e-06 | 220 | 165 | 11 | IPR001452 |
| Domain | IQ | 3.87e-05 | 71 | 165 | 6 | PF00612 | |
| Domain | zf-CCHC | 4.56e-05 | 23 | 165 | 4 | PF00098 | |
| Domain | IQ | 8.15e-05 | 81 | 165 | 6 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 1.46e-04 | 90 | 165 | 6 | IPR000048 | |
| Domain | IQ | 1.75e-04 | 93 | 165 | 6 | PS50096 | |
| Domain | RasGAP_C | 2.31e-04 | 3 | 165 | 2 | IPR000593 | |
| Domain | ZO | 2.31e-04 | 3 | 165 | 2 | IPR005417 | |
| Domain | RasGAP_C | 2.31e-04 | 3 | 165 | 2 | PF03836 | |
| Domain | ZF_CCHC | 2.48e-04 | 35 | 165 | 4 | PS50158 | |
| Domain | Cadherin_CS | 4.15e-04 | 109 | 165 | 6 | IPR020894 | |
| Domain | LLGL | 4.60e-04 | 4 | 165 | 2 | PF08366 | |
| Domain | Lethal2_giant | 4.60e-04 | 4 | 165 | 2 | IPR000664 | |
| Domain | LLGL2 | 4.60e-04 | 4 | 165 | 2 | IPR013577 | |
| Domain | CADHERIN_1 | 5.03e-04 | 113 | 165 | 6 | PS00232 | |
| Domain | Cadherin | 5.03e-04 | 113 | 165 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 5.27e-04 | 114 | 165 | 6 | PS50268 | |
| Domain | - | 5.27e-04 | 114 | 165 | 6 | 2.60.40.60 | |
| Domain | CA | 5.52e-04 | 115 | 165 | 6 | SM00112 | |
| Domain | Cadherin-like | 5.78e-04 | 116 | 165 | 6 | IPR015919 | |
| Domain | Cadherin | 6.33e-04 | 118 | 165 | 6 | IPR002126 | |
| Domain | SH3_1 | 6.45e-04 | 164 | 165 | 7 | PF00018 | |
| Domain | SH3_2 | 9.91e-04 | 86 | 165 | 5 | PF07653 | |
| Domain | SH3_2 | 9.91e-04 | 86 | 165 | 5 | IPR011511 | |
| Domain | G_PATCH | 1.05e-03 | 23 | 165 | 3 | PS50174 | |
| Domain | G_patch | 1.05e-03 | 23 | 165 | 3 | SM00443 | |
| Domain | G_patch_dom | 1.05e-03 | 23 | 165 | 3 | IPR000467 | |
| Domain | G-patch | 1.05e-03 | 23 | 165 | 3 | PF01585 | |
| Domain | Ricin_B_lectin | 1.35e-03 | 25 | 165 | 3 | PF00652 | |
| Domain | P-loop_NTPase | DHX16 MYO6 MYO7B SMC1A KIF1B DHX38 TRIP13 IQGAP1 MYO5C ARHGAP5 KIF3B TJP1 TJP2 ABCB11 SEPTIN10 AQR TDRD12 | 1.39e-03 | 848 | 165 | 17 | IPR027417 |
| Domain | ZnF_C2HC | 1.41e-03 | 55 | 165 | 4 | SM00343 | |
| Domain | Znf_CCHC | 1.41e-03 | 55 | 165 | 4 | IPR001878 | |
| Domain | DED_dom | 1.58e-03 | 7 | 165 | 2 | IPR001875 | |
| Domain | DED | 1.58e-03 | 7 | 165 | 2 | PF01335 | |
| Domain | DED | 1.58e-03 | 7 | 165 | 2 | PS50168 | |
| Domain | DED | 1.58e-03 | 7 | 165 | 2 | SM00031 | |
| Domain | Laminin_G | 1.72e-03 | 58 | 165 | 4 | IPR001791 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 3.58e-05 | 142 | 124 | 8 | MM15576 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ROCK2 IL32 IQGAP2 MYO6 MTMR1 IQGAP1 FMNL3 ARHGAP5 ARHGEF7 SH3PXD2A SRGAP1 NGEF TJP2 TOR1AIP1 | 4.11e-05 | 450 | 124 | 14 | M27078 |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 5.05e-05 | 149 | 124 | 8 | M41805 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 6.68e-05 | 155 | 124 | 8 | M41808 | |
| Pathway | BIOCARTA_D4GDI_PATHWAY | 1.38e-04 | 12 | 124 | 3 | M15513 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 6.34e-10 | 4 | 176 | 4 | 10469592 | |
| Pubmed | 6.34e-10 | 4 | 176 | 4 | 7983737 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-5 ERVK-19 ERVK-24 | 1.30e-09 | 94 | 176 | 9 | 21542922 |
| Pubmed | 2.41e-09 | 12 | 176 | 5 | 14557543 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 3.16e-09 | 5 | 176 | 4 | 12629516 | |
| Pubmed | SHANK1 ROCK2 CYLD CNTN4 DMXL2 IQGAP2 JAKMIP3 LMTK3 TMEM132B GSK3B GSN IQGAP1 CCDC13 TXLNA KIF3B FAM120A UBE2N TJP1 ARHGEF7 NGEF WDR1 CAP2 | 4.30e-09 | 963 | 176 | 22 | 28671696 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DHX16 FLNB MYO6 RPN1 RSL1D1 SMC1A UGGT1 DHX38 LARP1 EXOSC8 ZFC3H1 USP16 HNRNPAB NKRF GSN STT3B IQGAP1 TXLNA FAM120A TJP1 SRGAP1 TJP2 WDR1 AQR PTCD3 | 5.64e-09 | 1257 | 176 | 25 | 36526897 |
| Pubmed | SHANK1 CYLD CNTN4 NRIP1 FLNB DCHS2 DMXL2 PLK2 MYO6 RSL1D1 SMC1A KIF1B JAKMIP3 ZFC3H1 CMYA5 USP16 AKAP8L IQGAP1 ARHGAP5 CCDC13 FAM120A TJP1 NGEF C1S CAP2 | 8.72e-09 | 1285 | 176 | 25 | 35914814 | |
| Pubmed | ROCK2 EFCAB5 FLNB RARG PCDHGB7 IQGAP2 PCDHGB6 RPN1 CWC27 RSL1D1 GRK6 UGGT1 LARP1 ANKRD30B ZFC3H1 NEB TRIP13 HNRNPAB AKAP8L STT3B NDUFV2 IQGAP1 CLCN4 TJP1 SH3PXD2A SEPTIN10 | 1.99e-08 | 1442 | 176 | 26 | 35575683 | |
| Pubmed | DHX16 FLNB KIF1B SCYL1 LARP1 AKAP8L GSN IQGAP1 TJP1 TJP2 SEPTIN10 TOR1AIP1 PTCD3 | 4.39e-08 | 360 | 176 | 13 | 33111431 | |
| Pubmed | 6.70e-08 | 147 | 176 | 9 | 29576527 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DHX16 FLNB MYO6 RPN1 RSL1D1 SMC1A CAPN2 DHX38 EXOC3 CASP8 TRIP13 USP16 HNRNPAB AKAP8L NKRF GSK3B IQGAP1 LLGL1 FAM120A UFD1 PRR14L WDR1 AQR PTCD3 | 9.98e-08 | 1353 | 176 | 24 | 29467282 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | DHX16 PLK2 RSL1D1 SMC1A DHX38 LARP1 EXOC3 YES1 HNRNPAB AKAP8L SPAG5 IQGAP1 PTTG3P PPP2R5A LLGL2 FAM120A TJP1 RCOR3 COG5 TOR1AIP1 AQR PTCD3 | 1.07e-07 | 1155 | 176 | 22 | 20360068 |
| Pubmed | 1.27e-07 | 3 | 176 | 3 | 20602916 | ||
| Pubmed | CYLD DMXL2 MYO6 RPN1 RSL1D1 UGGT1 ETFA MTMR1 EXOC3 EXOSC8 ZFC3H1 YES1 USP16 TBC1D17 STT3B NDUFV2 TXLNA R3HCC1L LLGL1 FAM120A UBE2N CRYBG3 TOR1AIP1 AQR PTCD3 | 1.45e-07 | 1487 | 176 | 25 | 33957083 | |
| Pubmed | FLNB RSL1D1 UGGT1 SCYL1 LARP1 HNRNPAB FAM120A TJP1 RBM6 TJP2 PTCD3 | 1.72e-07 | 274 | 176 | 11 | 34244482 | |
| Pubmed | IQGAP2 MYO6 CWC27 SMC1A UGGT1 CAPN2 EXOC3 IQGAP1 PPP2R5A SCARB2 WDR1 COG5 TOR1AIP1 AQR PTCD3 | 1.95e-07 | 560 | 176 | 15 | 35241646 | |
| Pubmed | DHX16 DMXL2 DHX38 LARP1 EXOC3 AKAP8L NKRF TBC1D17 SPAG5 TXLNA LLGL2 LLGL1 FAM120A ARHGEF7 CRYBG3 AQR | 2.34e-07 | 650 | 176 | 16 | 38777146 | |
| Pubmed | A Large-scale genetic association study of esophageal adenocarcinoma risk. | DHX16 NRIP1 COL12A1 CAPN2 CASP8 CASP10 PTGIS GSK3B NFKB1 GUCY2D ABCB11 NOS3 | 2.65e-07 | 351 | 176 | 12 | 20453000 |
| Pubmed | KIAA0408 MYF6 NRIP1 FLNB DMXL2 COL12A1 RSL1D1 SMC1A KIF1B CMYA5 NEB FAM120A ALMS1 RCOR3 | 2.77e-07 | 497 | 176 | 14 | 23414517 | |
| Pubmed | FLNB IQGAP2 RPN1 RSL1D1 UGGT1 ETFA LARP1 YES1 TRIP13 HNRNPAB AKAP8L NKRF GSN SPAG5 STT3B IQGAP1 FAM120A SCARB2 NFKB1 UFD1 TJP2 WDR1 COG5 PTCD3 | 3.10e-07 | 1440 | 176 | 24 | 30833792 | |
| Pubmed | FLNB RPN1 RSL1D1 SMC1A DHX38 LARP1 EXOSC8 ZFC3H1 HNRNPAB AKAP8L NKRF GSN ARHGAP5 FAM120A TJP1 TJP2 TOR1AIP1 AQR | 3.47e-07 | 847 | 176 | 18 | 35850772 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DHX16 DMXL2 TCEAL7 RPN1 SMC1A MTMR1 EXOSC8 LMTK3 HNRNPAB AKAP8L NKRF STT3B NDUFV2 LLGL1 TJP1 ARHGEF7 RBM6 TNXB AQR PTCD3 | 6.73e-07 | 1082 | 176 | 20 | 38697112 |
| Pubmed | CRYBG2 SMC1A EXOSC8 USP16 LIN28A NKRF FAM120A ALMS1 UBE2N NFKB1 RCOR3 AQR PTCD3 | 8.95e-07 | 469 | 176 | 13 | 27634302 | |
| Pubmed | 1.04e-06 | 36 | 176 | 5 | 22421546 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DHX16 FLNB RSL1D1 SMC1A GRK6 UGGT1 ETFA EXOC3 YES1 TRIP13 HNRNPAB NKRF GSN IQGAP1 MYO5C TJP1 TJP2 TOR1AIP1 AQR | 1.23e-06 | 1024 | 176 | 19 | 24711643 |
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 1.26e-06 | 5 | 176 | 3 | 11401426 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ROCK2 FLNB SMC1A UGGT1 KIF1B CAPN2 DHX38 ETFA SCYL1 LARP1 CMYA5 TRIP13 HNRNPAB TBC1D17 IQGAP1 OTUD6B UFD1 TJP2 ANKMY2 WDR1 SEPTIN10 COG5 CAP2 | 1.38e-06 | 1455 | 176 | 23 | 22863883 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | ROCK2 FLNB DMXL2 IQGAP2 RSL1D1 DHX38 SCYL1 LARP1 YES1 GSK3B UBE2N TJP1 AQR | 1.74e-06 | 498 | 176 | 13 | 36634849 |
| Pubmed | 1.83e-06 | 18 | 176 | 4 | 18664271 | ||
| Pubmed | 2.52e-06 | 6 | 176 | 3 | 15063128 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ROCK2 FLNB RPN1 RSL1D1 SMC1A UGGT1 CAPN2 DHX38 LARP1 TRIP13 HNRNPAB GSN SPAG5 IQGAP1 TXLNA UBE2N TJP1 ARHGEF7 OTUD6B UFD1 AQR PTCD3 | 3.11e-06 | 1415 | 176 | 22 | 28515276 |
| Pubmed | 3.32e-06 | 234 | 176 | 9 | 36243803 | ||
| Pubmed | SHANK1 ROCK2 FLNB DMXL2 IQGAP2 MYO6 RPN1 KIF1B LARP1 MTMR1 HNRNPAB GSK3B GSN NDUFV2 IQGAP1 ARHGAP5 FAM120A TJP1 NGEF TJP2 WDR1 PTCD3 | 3.73e-06 | 1431 | 176 | 22 | 37142655 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | ROCK2 NPHP1 IQGAP2 SMC1A KIF1B SCYL1 LARP1 EXOC3 CDH23 NKRF PHF21A GSN SPAG5 STT3B IQGAP1 TXLNA KIF3B UBE2N SH3PXD2A NFKB1 ANKMY2 | 3.78e-06 | 1321 | 176 | 21 | 27173435 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | RPN1 RSL1D1 DHX38 ETFA LARP1 HNRNPAB AKAP8L NKRF GSN FAM120A RBM6 TJP2 WDR1 AQR PTCD3 | 3.96e-06 | 714 | 176 | 15 | 28302793 |
| Pubmed | 4.39e-06 | 7 | 176 | 3 | 16059920 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | CYLD MYO6 CWC27 RSL1D1 LARP1 EXOSC8 ZFC3H1 USP16 GSN STT3B TXLNA FAM120A TJP1 SH3PXD2A TJP2 | 4.68e-06 | 724 | 176 | 15 | 36232890 |
| Pubmed | FLNB DMXL2 IQGAP2 MYO6 SCYL1 LARP1 NDUFV2 IQGAP1 LLGL2 FAM120A TJP2 TOR1AIP1 | 4.83e-06 | 464 | 176 | 12 | 32457219 | |
| Pubmed | ATP8B3 DMXL2 PLK2 GRK6 CAPN2 YES1 HNRNPAB GSK3B STT3B MTMR7 LLGL2 KIF3B LLGL1 UBE2N PLA2G4F | 5.17e-06 | 730 | 176 | 15 | 34857952 | |
| Pubmed | 5.86e-06 | 251 | 176 | 9 | 27507650 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MYO6 RSL1D1 DHX38 ETFA LARP1 USP16 HNRNPAB NKRF PHF21A SPAG5 R3HCC1L ALMS1 TJP1 RPRD2 PRR14L WDR1 TOR1AIP1 | 5.95e-06 | 934 | 176 | 17 | 33916271 |
| Pubmed | DHX16 ROCK2 RPN1 SMC1A DHX38 SCYL1 LARP1 EXOC3 NKRF SPAG5 STT3B TXLNA UFD1 PTCD3 | 6.69e-06 | 653 | 176 | 14 | 33742100 | |
| Pubmed | DHX16 FLNB RSL1D1 UGGT1 DHX38 LARP1 NKRF IQGAP1 FAM120A TJP1 RBM6 TJP2 AQR PTCD3 | 6.69e-06 | 653 | 176 | 14 | 22586326 | |
| Pubmed | 7.00e-06 | 8 | 176 | 3 | 9337844 | ||
| Pubmed | 7.38e-06 | 25 | 176 | 4 | 16374509 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CYLD AGPAT5 KIF1B ETFA CASP8 YES1 SPAG5 IQGAP1 ARHGAP5 TXLNA PPP2R3A FAM120A ALMS1 TJP1 NFKB1 TJP2 | 7.80e-06 | 853 | 176 | 16 | 28718761 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | IQGAP2 RPN1 RSL1D1 SMC1A LARP1 EXOSC8 ZFC3H1 HNRNPAB AKAP8L NKRF IQGAP1 TXLNA FAM120A RBM6 AQR | 8.21e-06 | 759 | 176 | 15 | 35915203 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | ROCK2 IQGAP2 MYO6 RPN1 RSL1D1 SMC1A UGGT1 KIF1B DHX38 LARP1 CMYA5 HNRNPAB AKAP8L GSK3B GSN IQGAP1 TXLNA ARHGEF7 TJP2 PTCD3 | 8.81e-06 | 1284 | 176 | 20 | 17353931 |
| Pubmed | DHX16 ROCK2 FLNB COL12A1 RPN1 RSL1D1 UGGT1 LARP1 YES1 TRIP13 HNRNPAB GSK3B STT3B FAT1 FAM120A UBE2N TJP1 SCARB2 TOR1AIP1 AQR | 1.02e-05 | 1297 | 176 | 20 | 33545068 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | ROCK2 FLNB SMC1A UGGT1 CAPN2 ETFA MTMR1 GSN STT3B MTMR7 FAM120A TJP1 UFD1 TJP2 ANKMY2 WDR1 PTCD3 | 1.02e-05 | 974 | 176 | 17 | 28675297 |
| Pubmed | 1.49e-05 | 10 | 176 | 3 | 12970426 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | CYLD FLNB COL11A2 MYO6 RPN1 SMC1A DHX38 TRIP13 USP16 IQGAP1 UBE2N TJP1 OTUD6B UFD1 MARK4 TJP2 AQR | 1.53e-05 | 1005 | 176 | 17 | 19615732 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | DHX16 ROCK2 FLNB RSL1D1 SMC1A DHX38 LARP1 HNRNPAB AKAP8L NKRF FAM120A UBE2N RBM6 AQR PTCD3 | 1.68e-05 | 807 | 176 | 15 | 22681889 |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | MYO6 RSL1D1 LARP1 ZFC3H1 NKRF GSN SPAG5 MYO5C RPRD2 TOR1AIP1 | 1.69e-05 | 361 | 176 | 10 | 30344098 |
| Pubmed | EFCAB5 RPN1 RSL1D1 SMC1A KIF1B LARP1 HNRNPAB NKRF GSK3B IQGAP1 TXLNA FAM120A OTUD6B ALPK2 PTCD3 | 1.73e-05 | 809 | 176 | 15 | 32129710 | |
| Pubmed | ROCK2 MYO6 RPN1 SMC1A KIF1B ETFA LARP1 YES1 TRIP13 AKAP8L NKRF GSK3B IQGAP1 FAM120A UBE2N TJP1 RCOR3 WDR1 AQR | 2.03e-05 | 1247 | 176 | 19 | 27684187 | |
| Pubmed | SHANK1 CYLD FLNB DMXL2 RPN1 CAPN2 ETFA HNRNPAB AKAP8L STT3B NDUFV2 UBE2N TJP1 ARHGEF7 TJP2 CRYBG3 SEPTIN10 PTCD3 | 2.10e-05 | 1139 | 176 | 18 | 36417873 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | FLNB IQGAP2 MYO6 RSL1D1 SMC1A UGGT1 ETFA LARP1 MTMR1 EXOSC8 TRIP13 HNRNPAB AKAP8L GSN IQGAP1 FAM120A WDR1 PTCD3 | 2.36e-05 | 1149 | 176 | 18 | 35446349 |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 20644164 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 29971953 | ||
| Pubmed | Gas6 anti-apoptotic signaling requires NF-kappa B activation. | 2.55e-05 | 2 | 176 | 2 | 11425860 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 16251207 | ||
| Pubmed | Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B. | 2.55e-05 | 2 | 176 | 2 | 12185535 | |
| Pubmed | The zonula occludens protein family regulates the hepatic barrier system in the murine liver. | 2.55e-05 | 2 | 176 | 2 | 33184034 | |
| Pubmed | Glycogen synthase kinase-3 beta regulates NF-kappa B1/p105 stability. | 2.55e-05 | 2 | 176 | 2 | 12871932 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 22219375 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 18055457 | ||
| Pubmed | Hugl1 and Hugl2 in mammary epithelial cells: polarity, proliferation, and differentiation. | 2.55e-05 | 2 | 176 | 2 | 23110097 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 15226292 | ||
| Pubmed | ZO-1- and ZO-2-dependent integration of myosin-2 to epithelial zonula adherens. | 2.55e-05 | 2 | 176 | 2 | 18596233 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 23861985 | ||
| Pubmed | Clinicopathological significance of caspase-8 and caspase-10 expression in rectal cancer. | 2.55e-05 | 2 | 176 | 2 | 18716417 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 23728913 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 24905925 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 7542259 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 27693639 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 17217619 | ||
| Pubmed | IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma. | 2.55e-05 | 2 | 176 | 2 | 20977743 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 21124868 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 22843554 | ||
| Pubmed | A synthetic lethal screen identifies FAT1 as an antagonist of caspase-8 in extrinsic apoptosis. | 2.55e-05 | 2 | 176 | 2 | 24442637 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 21110852 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 9060628 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 17942533 | ||
| Pubmed | Effects of the differential expression of ZO-1 and ZO-2 on podocyte structure and function. | 2.55e-05 | 2 | 176 | 2 | 29845705 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 10966866 | ||
| Pubmed | Development of hepatocellular carcinoma in Iqgap2-deficient mice is IQGAP1 dependent. | 2.55e-05 | 2 | 176 | 2 | 18180285 | |
| Pubmed | Unique and overlapping substrate specificities of caspase-8 and caspase-10. | 2.55e-05 | 2 | 176 | 2 | 16186808 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 28028966 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 30266988 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 170210 | ||
| Pubmed | Expression of CYLD and NF-kappaB in human cholesteatoma epithelium. | 2.55e-05 | 2 | 176 | 2 | 20414373 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 28445729 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 11583996 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 17644577 | ||
| Pubmed | Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene. | 2.55e-05 | 2 | 176 | 2 | 11086080 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 16923393 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 18563783 | ||
| Pubmed | Association of KIR2DL5B gene with celiac disease supports the susceptibility locus on 19q13.4. | 2.55e-05 | 2 | 176 | 2 | 17215859 | |
| Interaction | DYSF interactions | 8.26e-07 | 62 | 168 | 7 | int:DYSF | |
| Interaction | PARD6A interactions | 3.97e-06 | 78 | 168 | 7 | int:PARD6A | |
| Interaction | CDC42 interactions | ROCK2 IQGAP2 MYO6 RPN1 RSL1D1 GRK6 ETFA SCYL1 MTMR1 EXOC3 YES1 HNRNPAB STT3B IQGAP1 FMNL3 TGFBR2 MSRB2 ARHGAP5 FAT1 LLGL1 TJP1 ARHGEF7 SH3PXD2A SRGAP1 MARK4 SEPTIN10 COG5 TOR1AIP1 | 4.66e-06 | 1323 | 168 | 28 | int:CDC42 |
| Interaction | SIPA1L1 interactions | 1.58e-05 | 174 | 168 | 9 | int:SIPA1L1 | |
| Interaction | ZYX interactions | CYLD IQGAP2 ETFA PHF21A SPAG5 ARHGAP5 ALMS1 UBE2N TJP1 ARHGEF7 TJP2 CRYBG3 | 2.13e-05 | 329 | 168 | 12 | int:ZYX |
| Interaction | CIT interactions | DHX16 CYLD NRIP1 FLNB MYO6 RPN1 RSL1D1 SMC1A DHX38 ETFA LARP1 IRF5 CMYA5 TRIP13 HNRNPAB AKAP8L NKRF GSN IQGAP1 MSRB2 FAM120A ALMS1 TJP1 TJP2 PRR14L WDR1 TOR1AIP1 AQR | 2.53e-05 | 1450 | 168 | 28 | int:CIT |
| Interaction | VASP interactions | CYLD GSN SPAG5 IQGAP1 ARHGAP5 FAT1 R3HCC1L ALMS1 UBE2N TJP1 TJP2 | 3.76e-05 | 294 | 168 | 11 | int:VASP |
| Interaction | PTPA interactions | 5.08e-05 | 115 | 168 | 7 | int:PTPA | |
| Interaction | HOOK3 interactions | 5.12e-05 | 202 | 168 | 9 | int:HOOK3 | |
| Interaction | MYO19 interactions | 5.22e-05 | 252 | 168 | 10 | int:MYO19 | |
| Interaction | DTNBP1 interactions | 6.56e-05 | 162 | 168 | 8 | int:DTNBP1 | |
| Interaction | RHOJ interactions | ROCK2 IQGAP2 RPN1 RSL1D1 MTMR1 EXOC3 YES1 STT3B IQGAP1 TGFBR2 ARHGAP5 FAT1 LLGL1 ARHGEF7 SEPTIN10 TOR1AIP1 | 8.25e-05 | 633 | 168 | 16 | int:RHOJ |
| Interaction | GLDC interactions | FLNB RSL1D1 UGGT1 SCYL1 LARP1 HNRNPAB FAM120A TJP1 RBM6 TJP2 PTCD3 | 8.28e-05 | 321 | 168 | 11 | int:GLDC |
| GeneFamily | Cadherin related | 3.01e-06 | 17 | 111 | 4 | 24 | |
| GeneFamily | Beta-gamma crystallin domain containing | 1.12e-04 | 3 | 111 | 2 | 1360 | |
| GeneFamily | Membrane associated guanylate kinases|PDZ domain containing|Scribble complex | 2.22e-04 | 4 | 111 | 2 | 1224 | |
| GeneFamily | CD molecules|Tumor necrosis factor receptor superfamily|Death inducing signaling complex | 5.51e-04 | 6 | 111 | 2 | 1342 | |
| GeneFamily | Caspases|Death effector domain containing|Ripoptosome|Death inducing signaling complex | 7.69e-04 | 7 | 111 | 2 | 1019 | |
| GeneFamily | Oligosaccharyltransferase complex subunits | 2.37e-03 | 12 | 111 | 2 | 445 | |
| GeneFamily | Caspases|Caspase recruitment domain containing | 2.79e-03 | 13 | 111 | 2 | 468 | |
| GeneFamily | Fibronectin type III domain containing | 3.08e-03 | 160 | 111 | 5 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.16e-03 | 161 | 111 | 5 | 593 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 3.72e-03 | 15 | 111 | 2 | 696 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 3.72e-03 | 15 | 111 | 2 | 903 | |
| GeneFamily | DEAH-box helicases | 4.24e-03 | 16 | 111 | 2 | 500 | |
| GeneFamily | Actins|Deafness associated genes | 5.19e-03 | 113 | 111 | 4 | 1152 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 5.36e-03 | 18 | 111 | 2 | 620 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 7.96e-03 | 22 | 111 | 2 | 579 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ROCK2 NRIP1 FLNB DMXL2 CASP8 ZNF804A MBOAT2 GSK3B PHF21A TGFBR2 FAT1 PPP2R3A PPP2R5A ARHGEF7 NFKB1 RBM6 TJP2 ANKMY2 CRYBG3 COG5 AQR CAP2 | 2.65e-08 | 856 | 166 | 22 | M4500 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | FLNB SMC1A KIF1B GSN ARHGAP5 KIF3B LLGL1 ALMS1 ARHGEF7 MARK4 | 6.04e-07 | 199 | 166 | 10 | M5893 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ROCK2 NRIP1 FLNB CASP8 ZNF804A GSK3B PHF21A FAT1 PPP2R3A ARHGEF7 RBM6 TJP2 ANKMY2 CAP2 | 1.75e-06 | 466 | 166 | 14 | M13522 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HENDO | FLNB PLK2 IL32 RARG IQGAP2 MYO6 ISM1 YES1 GALNT18 IQGAP1 MYO5C FMNL3 TGFBR2 TJP1 CD27 SH3PXD2A SERINC5 WDR1 NOS3 | 3.83e-06 | 888 | 166 | 19 | M39049 |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_DN | 5.09e-06 | 198 | 166 | 9 | M9407 | |
| Coexpression | SESTO_RESPONSE_TO_UV_C5 | 1.07e-05 | 46 | 166 | 5 | M1470 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | ROCK2 SMC1A YES1 TRIP13 GSK3B TGFBR2 FAT1 UBE2N ARHGEF7 RBM6 TJP2 COG5 CAP2 | 1.29e-05 | 481 | 166 | 13 | M3898 |
| Coexpression | CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP | 2.29e-05 | 239 | 166 | 9 | M4716 | |
| Coexpression | GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP | 4.01e-05 | 198 | 166 | 8 | M3324 | |
| Coexpression | GSE29618_BCELL_VS_PDC_DN | 4.01e-05 | 198 | 166 | 8 | M4942 | |
| Coexpression | GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_UP | 4.15e-05 | 199 | 166 | 8 | M4607 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_DN | 4.15e-05 | 199 | 166 | 8 | M5249 | |
| Coexpression | GSE12198_CTRL_VS_HIGH_IL2_STIM_NK_CELL_DN | 4.30e-05 | 200 | 166 | 8 | M7070 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN | 4.30e-05 | 200 | 166 | 8 | M6621 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 5.76e-05 | 269 | 166 | 9 | M41203 | |
| Coexpression | DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN | 6.20e-05 | 34 | 166 | 4 | M7439 | |
| Coexpression | LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP | 8.63e-05 | 14 | 166 | 3 | M540 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | FLNB PLK2 IL32 MYO6 CAPN2 YES1 GALNT18 TJP1 CD27 SERINC5 NOS3 | 1.21e-04 | 440 | 166 | 11 | M39039 |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.47e-07 | 178 | 165 | 8 | 60263c0bb9de3a57ba2ba543262a2ace0066fd85 | |
| ToppCell | IIH-matDC-|IIH / Condition, Cell_class and T cell subcluster | 3.62e-07 | 179 | 165 | 8 | 46074b2781ed79e2979428b3ec81504621d3903c | |
| ToppCell | IIH-matDC|IIH / Condition, Cell_class and T cell subcluster | 3.62e-07 | 179 | 165 | 8 | 5999c85ce3bab5309ff1ed154be7e32b037750b1 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.10e-07 | 182 | 165 | 8 | 997d37ca2af661c92a56add888762724dfccc890 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-07 | 184 | 165 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-07 | 184 | 165 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-07 | 184 | 165 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.65e-07 | 185 | 165 | 8 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.04e-07 | 187 | 165 | 8 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-07 | 189 | 165 | 8 | e60a3d6aa84788c29f23439f1c747431ea581bc3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.40e-07 | 193 | 165 | 8 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | Transverse-Dendritic_cell-Lymphoid_DC|Transverse / Region, Cell class and subclass | 7.47e-07 | 197 | 165 | 8 | a58af0ea82f76f2a7abac1f62629ff20d552fc63 | |
| ToppCell | Transverse-(5)_Dendritic_cell-(53)_Lymphoid_DC|Transverse / shred on region, Cell_type, and subtype | 7.47e-07 | 197 | 165 | 8 | 15b87fd3906d7388c271d30d0c64b1bcc490801c | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 8.06e-07 | 199 | 165 | 8 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 8.06e-07 | 199 | 165 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.06e-07 | 199 | 165 | 8 | 1fd7bbb8727607e6507848602a19bc86882ef2d5 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.06e-07 | 199 | 165 | 8 | 9672230aa0bc6a7289050c955f5154ca183a5159 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.06e-07 | 199 | 165 | 8 | e18abe678da293bd01fae55e2f9ab6fdd643d02d | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 8.06e-07 | 199 | 165 | 8 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.37e-07 | 200 | 165 | 8 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.37e-07 | 200 | 165 | 8 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | 15-Airway|15 / Age, Tissue, Lineage and Cell class | 8.37e-07 | 200 | 165 | 8 | ba4b8d5becf81351901c2ecac74ffa28e29586f3 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.37e-07 | 200 | 165 | 8 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.30e-06 | 176 | 165 | 7 | 1af28b701c4598ce761f85adbd5d79e4918d265a | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-1|TCGA-Liver / Sample_Type by Project: Shred V9 | 4.63e-06 | 178 | 165 | 7 | 51c59dabf2d7aef1b1964f6f766d5ec07ef90f5a | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.80e-06 | 179 | 165 | 7 | dcd0a83f0592ae27f814d064b4791f84c3c86e64 | |
| ToppCell | Thalamus-Macroglia|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.16e-06 | 181 | 165 | 7 | 4f62b63854a4e9fea6e839f0340e78392c66fb0e | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 5.35e-06 | 182 | 165 | 7 | 354dcdb01360597f68c4fe157a682aee1c0b8bb1 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-chondrocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.35e-06 | 182 | 165 | 7 | ed487f3a774812caa2903a646b60c86edcc1e65e | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.35e-06 | 182 | 165 | 7 | d179b5deb07c20d49eb6c58d5a65904f8921de3a | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.35e-06 | 182 | 165 | 7 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.55e-06 | 183 | 165 | 7 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.55e-06 | 183 | 165 | 7 | 07ca2786e62eca9feecf5e54a11864a960f7641a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.62e-06 | 188 | 165 | 7 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.62e-06 | 188 | 165 | 7 | 0026c9479b30fb39daa91cfa220a88f9c9e65fe7 | |
| ToppCell | T_cells-Central_memory_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 7.86e-06 | 193 | 165 | 7 | 725326d7e3604736b607c19f4069c81cb4f2d20c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.13e-06 | 194 | 165 | 7 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Tumor-Diffuse_large_B-cell_lymphoma-DLBCL-1|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 8.13e-06 | 194 | 165 | 7 | eaeeb84576270cc3fc59002ba33bff9639bb0b02 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Scara5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-06 | 195 | 165 | 7 | d663d54a4bcc94e2c9b50ed931e2b2db4ca41373 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-06 | 195 | 165 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.41e-06 | 195 | 165 | 7 | ec12cfb2fce44cc2de4e198ef5af075e626f0329 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.41e-06 | 195 | 165 | 7 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.41e-06 | 195 | 165 | 7 | ccfb80e3bfdf5304fa798e0a47b473955ecc0c6d | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-06 | 195 | 165 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-06 | 195 | 165 | 7 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.98e-06 | 197 | 165 | 7 | 98e34e8612f111bb667a574de1faaa785d318ca4 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.98e-06 | 197 | 165 | 7 | c747c496ac090309b7f8a3e9d840928f12c83f2f | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.98e-06 | 197 | 165 | 7 | 131bc6ef55f467cc802db68daf7e7d757ea64fc6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.98e-06 | 197 | 165 | 7 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | Transverse-Dendritic_cell-Lymphoid_DC|Dendritic_cell / Region, Cell class and subclass | 8.98e-06 | 197 | 165 | 7 | 8545baf923ddf84c5ce9414a36d810603be52401 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.28e-06 | 198 | 165 | 7 | ff8a9adc1302a4679ccdfe9ef95ef53e4c7a5391 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.28e-06 | 198 | 165 | 7 | 09e452742aed9f48bf1ffc35c6b06a296bcfe076 | |
| ToppCell | 18-Airway|18 / Age, Tissue, Lineage and Cell class | 9.28e-06 | 198 | 165 | 7 | 3cdfcc6445858c3c54058bbd90b20b88b1771cca | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.59e-06 | 199 | 165 | 7 | b9338b739162cd8e5661c9a4dcb41a31219b5723 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 9.59e-06 | 199 | 165 | 7 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.59e-06 | 199 | 165 | 7 | c972d3036151403f26fa9d6271520639c281ab84 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.59e-06 | 199 | 165 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.59e-06 | 199 | 165 | 7 | fb580e9321ddf97c73b2e356cd82523db74a38a2 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.59e-06 | 199 | 165 | 7 | 1ae244b563f85c1ee8d22698f478c842a4d9c7f5 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Fibroblasts|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.59e-06 | 199 | 165 | 7 | f19c683f38bca3bfee40396f27423441051dec67 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.59e-06 | 199 | 165 | 7 | 67f78c070c56e44fba36542041bf7fa1c291807c | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.59e-06 | 199 | 165 | 7 | 56d72da6a5fab9cbb2975fe6f87a631debaba6a8 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 9.91e-06 | 200 | 165 | 7 | 69b41f5fb370aa8840a9ad7919d03ef1e57d1b5b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 9.91e-06 | 200 | 165 | 7 | 0f4b8b0868bda406fe6bf01d1b722510fdfd0168 | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.91e-06 | 200 | 165 | 7 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.91e-06 | 200 | 165 | 7 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.91e-06 | 200 | 165 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 9.91e-06 | 200 | 165 | 7 | 2022df85df94ab8cbb4e80e3fe9894c01051c5e0 | |
| ToppCell | normal_Lung-Fibroblasts-COL14A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 9.91e-06 | 200 | 165 | 7 | 6d8f6a6b3f61c529fbed1376659641030abf4f2c | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.91e-06 | 200 | 165 | 7 | 3c898e81444b001835c3f1bbc68183078701b135 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.91e-06 | 200 | 165 | 7 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.91e-06 | 200 | 165 | 7 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.13e-05 | 135 | 165 | 6 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.38e-05 | 154 | 165 | 6 | 8dc8f02534c3ebda30bf9e702e36d0c53d89e5a5 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 160 | 165 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 160 | 165 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.75e-05 | 167 | 165 | 6 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.75e-05 | 167 | 165 | 6 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 3.88e-05 | 168 | 165 | 6 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_ETV4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.01e-05 | 169 | 165 | 6 | 716e9d4c5fb99c56b76afaa5ed90bfa859fde802 | |
| ToppCell | CV-Mild-7|CV / Virus stimulation, Condition and Cluster | 4.15e-05 | 170 | 165 | 6 | 25ebde7d2f8ae1afdfaf5876284ff20bb179eb10 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 4.15e-05 | 170 | 165 | 6 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-ABC_aged-B_naive|bone_marrow / Manually curated celltypes from each tissue | 4.28e-05 | 171 | 165 | 6 | fcc31a9a69f96de10d1324a5a4fbfe4289bf4984 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-05 | 171 | 165 | 6 | a31c23406cf6d6a17358a8fb41d392a7fb0306e0 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-05 | 171 | 165 | 6 | 43d8fd9b9546e84a652564fe96b514b34b06262b | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.43e-05 | 172 | 165 | 6 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | Ionocyte-iono-2|World / Class top | 4.57e-05 | 173 | 165 | 6 | e5ec28ccc5e048fd98de4c876e5c53b866b66228 | |
| ToppCell | CV-Mild-7|Mild / Virus stimulation, Condition and Cluster | 4.57e-05 | 173 | 165 | 6 | c9bbca9313a0fdf146c8c995624b94b937e818d8 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-aDC_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.19e-05 | 177 | 165 | 6 | ccf5dc54780d6039a4d062dee88440c011ddc0a3 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.36e-05 | 178 | 165 | 6 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 5.52e-05 | 179 | 165 | 6 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.52e-05 | 179 | 165 | 6 | d1ef7e1cb00336118e387b47f4f8120f53584391 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.52e-05 | 179 | 165 | 6 | 58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.70e-05 | 180 | 165 | 6 | 30cf3c7ee29694eaccb89bf8053a82037d5c9f1d | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.88e-05 | 181 | 165 | 6 | e1ae9ada60ec89e7a7cde9c231c1a099ed2ffecc | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.88e-05 | 181 | 165 | 6 | 13270b6ba6a9c8e5681c6f40000c643ce1d9344a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_IL7R|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.88e-05 | 181 | 165 | 6 | 3e3c903b522dced6bec5dc447cc3f8bf9a9749e3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.88e-05 | 181 | 165 | 6 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.88e-05 | 181 | 165 | 6 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.88e-05 | 181 | 165 | 6 | 8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9 | |
| Disease | Nonsyndromic Deafness | 8.09e-05 | 81 | 160 | 5 | C3711374 | |
| Disease | muscle measurement | 1.74e-04 | 4 | 160 | 2 | EFO_0004515 | |
| Disease | Metastatic melanoma | 2.13e-04 | 54 | 160 | 4 | C0278883 | |
| Disease | osteoarthritis | 2.19e-04 | 222 | 160 | 7 | MONDO_0005178 | |
| Disease | Sensorineural Hearing Loss (disorder) | 2.56e-04 | 23 | 160 | 3 | C0018784 | |
| Disease | neuroblastoma (implicated_via_orthology) | 2.89e-04 | 5 | 160 | 2 | DOID:769 (implicated_via_orthology) | |
| Disease | lymphocyte count | IPPK ROCK2 NRIP1 FLNB PLK2 RIPOR2 PCDHGB7 IQGAP2 PCDHGB6 KIF1B ETV1 CDH23 CASP8 IRF5 IQGAP1 ALMS1 NFKB1 MARK4 GSG1L | 3.84e-04 | 1464 | 160 | 19 | EFO_0004587 |
| Disease | Autoimmune lymphoproliferative syndrome | 4.32e-04 | 6 | 160 | 2 | cv:CN301239 | |
| Disease | Autosomal dominant nonsyndromic hearing loss | 5.15e-04 | 29 | 160 | 3 | cv:C5779548 | |
| Disease | asthma, response to diisocyanate | 5.78e-04 | 261 | 160 | 7 | EFO_0006995, MONDO_0004979 | |
| Disease | Intrahepatic Cholestasis | 6.03e-04 | 7 | 160 | 2 | C0008372 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 6.29e-04 | 346 | 160 | 8 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | Brain Tumor, Primary | 7.58e-04 | 33 | 160 | 3 | C0750974 | |
| Disease | Primary malignant neoplasm of brain | 7.58e-04 | 33 | 160 | 3 | C0750979 | |
| Disease | Recurrent Brain Neoplasm | 7.58e-04 | 33 | 160 | 3 | C0750977 | |
| Disease | Benign neoplasm of brain, unspecified | 7.58e-04 | 33 | 160 | 3 | C0496899 | |
| Disease | Neoplasms, Intracranial | 7.58e-04 | 33 | 160 | 3 | C1527390 | |
| Disease | Nonsyndromic genetic hearing loss | 7.89e-04 | 76 | 160 | 4 | cv:C5680182 | |
| Disease | Autoimmune Lymphoproliferative Syndrome | 8.01e-04 | 8 | 160 | 2 | C1328840 | |
| Disease | cervical cancer | 8.28e-04 | 34 | 160 | 3 | C4048328 | |
| Disease | sleep duration | 8.42e-04 | 362 | 160 | 8 | EFO_0005271 | |
| Disease | Uterine Cervical Neoplasm | 9.02e-04 | 35 | 160 | 3 | C0007873 | |
| Disease | lifestyle measurement, anxiety disorder measurement | 9.25e-04 | 137 | 160 | 5 | EFO_0007795, EFO_0010724 | |
| Disease | serum alanine aminotransferase measurement | NRIP1 IL32 COL12A1 AGPAT5 CASP8 CASP10 CMYA5 USP16 MARK4 RBM6 TJP2 ABCB11 GRHL3 | 9.45e-04 | 869 | 160 | 13 | EFO_0004735 |
| Disease | HEPATOCELLULAR CARCINOMA | 1.03e-03 | 9 | 160 | 2 | 114550 | |
| Disease | centronuclear myopathy X-linked (implicated_via_orthology) | 1.03e-03 | 9 | 160 | 2 | DOID:0111225 (implicated_via_orthology) | |
| Disease | Adult Hepatocellular Carcinoma | 1.03e-03 | 9 | 160 | 2 | C0279607 | |
| Disease | Hepatocellular carcinoma | 1.03e-03 | 9 | 160 | 2 | cv:C2239176 | |
| Disease | Cardiomegaly | 1.05e-03 | 82 | 160 | 4 | C0018800 | |
| Disease | Cardiac Hypertrophy | 1.05e-03 | 82 | 160 | 4 | C1383860 | |
| Disease | cortical surface area measurement | DHX16 ROCK2 EFCAB5 FLNB DCHS2 IQGAP2 FAT3 KIF1B CAPN2 ETFA LIN28A PHF21A STPG2 TJP1 NFKB1 WDR1 TNXB | 1.05e-03 | 1345 | 160 | 17 | EFO_0010736 |
| Disease | Schizophrenia | SHANK1 NRIP1 GRK6 CMYA5 CSMD2 ZNF804A GSK3B GSN NDUFV2 SH3PXD2A UFD1 ERVK-8 TNXB | 1.09e-03 | 883 | 160 | 13 | C0036341 |
| Disease | Malignant neoplasm of brain | 1.15e-03 | 38 | 160 | 3 | C0153633 | |
| Disease | Brain Neoplasms | 1.24e-03 | 39 | 160 | 3 | C0006118 | |
| Disease | Essential hypertension | 1.28e-03 | 10 | 160 | 2 | cv:C0085580 | |
| Disease | Essential hypertension, genetic | 1.28e-03 | 10 | 160 | 2 | cv:CN305331 | |
| Disease | HYPERTENSION, ESSENTIAL | 1.28e-03 | 10 | 160 | 2 | 145500 | |
| Disease | kidney cancer (implicated_via_orthology) | 1.56e-03 | 11 | 160 | 2 | DOID:263 (implicated_via_orthology) | |
| Disease | Paroxysmal atrial fibrillation | 1.65e-03 | 156 | 160 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 1.65e-03 | 156 | 160 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.65e-03 | 156 | 160 | 5 | C2585653 | |
| Disease | Squamous cell carcinoma of esophagus | 1.81e-03 | 95 | 160 | 4 | C0279626 | |
| Disease | Atrial Fibrillation | 1.84e-03 | 160 | 160 | 5 | C0004238 | |
| Disease | cleft palate (is_implicated_in) | 1.86e-03 | 12 | 160 | 2 | DOID:674 (is_implicated_in) | |
| Disease | Essential Hypertension | 1.86e-03 | 12 | 160 | 2 | C0085580 | |
| Disease | hydroxy-leucine measurement | 1.88e-03 | 45 | 160 | 3 | EFO_0005276 | |
| Disease | heart rate variability measurement, response to antipsychotic drug | 2.00e-03 | 46 | 160 | 3 | EFO_0008003, GO_0097332 | |
| Disease | age-related hearing impairment | 2.01e-03 | 324 | 160 | 7 | EFO_0005782 | |
| Disease | Primary biliary cirrhosis | 2.13e-03 | 47 | 160 | 3 | C0008312 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 2.19e-03 | 13 | 160 | 2 | C1846647 | |
| Disease | Bardet-Biedl Syndrome | 2.19e-03 | 13 | 160 | 2 | C0752166 | |
| Disease | hemoglobin A1 measurement | 2.21e-03 | 520 | 160 | 9 | EFO_0007629 | |
| Disease | monocyte count | NRIP1 FLNB RASGRP4 CRYBG2 PLK2 SZT2 RPN1 KIF1B NAGLU CDH23 CASP8 GSK3B KIF3B NFKB1 MARK4 GSG1L | 2.26e-03 | 1320 | 160 | 16 | EFO_0005091 |
| Disease | schizophrenia, anorexia nervosa | 2.26e-03 | 48 | 160 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | frontal fibrosing alopecia | 2.26e-03 | 48 | 160 | 3 | EFO_0009855 | |
| Disease | cholestasis (biomarker_via_orthology) | 2.40e-03 | 49 | 160 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 2.69e-03 | 51 | 160 | 3 | cv:CN043650 | |
| Disease | Congestive heart failure | 3.08e-03 | 110 | 160 | 4 | C0018802 | |
| Disease | Heart failure | 3.08e-03 | 110 | 160 | 4 | C0018801 | |
| Disease | Left-Sided Heart Failure | 3.08e-03 | 110 | 160 | 4 | C0023212 | |
| Disease | Heart Failure, Right-Sided | 3.08e-03 | 110 | 160 | 4 | C0235527 | |
| Disease | Heart Decompensation | 3.08e-03 | 110 | 160 | 4 | C1961112 | |
| Disease | Myocardial Failure | 3.08e-03 | 110 | 160 | 4 | C1959583 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 3.14e-03 | 181 | 160 | 5 | DOID:684 (is_implicated_in) | |
| Disease | severe acute respiratory syndrome, COVID-19 | 3.15e-03 | 447 | 160 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | anthranilic acid measurement | 3.34e-03 | 16 | 160 | 2 | EFO_0010460 | |
| Disease | alkaline phosphatase measurement | RIPOR2 AGPAT5 DHX38 IRF5 GSK3B GSN LLGL1 MARK4 ABCB11 PRR14L GSG1L COG5 ALPK2 | 3.67e-03 | 1015 | 160 | 13 | EFO_0004533 |
| Disease | macula measurement | 3.77e-03 | 189 | 160 | 5 | EFO_0008375 | |
| Disease | platelet-to-lymphocyte ratio | 3.77e-03 | 363 | 160 | 7 | EFO_0008446 | |
| Disease | alcoholic hepatitis (biomarker_via_orthology) | 4.22e-03 | 18 | 160 | 2 | DOID:12351 (biomarker_via_orthology) | |
| Disease | essential hypertension (is_implicated_in) | 4.22e-03 | 18 | 160 | 2 | DOID:10825 (is_implicated_in) | |
| Disease | Bipolar Disorder | 4.64e-03 | 477 | 160 | 8 | C0005586 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 4.70e-03 | 19 | 160 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Systemic Scleroderma | 4.70e-03 | 19 | 160 | 2 | C0036421 | |
| Disease | cognitive function measurement | EFCAB5 CNTN4 DMXL2 PLK2 RARG SZT2 BRINP1 ZNF804A GALNT18 FAM120A ALMS1 FMN1 SRGAP1 RBM6 SEPTIN10 TNXB | 5.03e-03 | 1434 | 160 | 16 | EFO_0008354 |
| Disease | Colorectal Carcinoma | SHANK1 CNTN4 PDGFRL ETV1 CASP8 BRINP1 ZNF804A TGFBR2 FAT1 ABCB11 | 5.11e-03 | 702 | 160 | 10 | C0009402 |
| Disease | carcinoma (implicated_via_orthology) | 5.12e-03 | 64 | 160 | 3 | DOID:305 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PGIKAEPDESNARYF | 21 | P61088 | |
| PGIKAEPDESNARYF | 21 | Q5JXB2 | |
| EVDPTVFEVPNGYSV | 456 | Q6ZTN6 | |
| EPPNPFSERVYTEKD | 16 | Q9BXX2 | |
| SDTFEIYDPRNPVNK | 441 | Q6UX04 | |
| EPEVPAYSIRKGLQF | 1041 | Q7Z408 | |
| KYRSNKGESPVEPAE | 216 | P26842 | |
| EGSTIPIQEDYRKPE | 241 | P26842 | |
| EPVSKYFRVQDSPGR | 2261 | Q68DQ2 | |
| TPEGTYVSPFKDVRQ | 281 | O15254 | |
| GPVDLSDPSKRQFYI | 636 | O60477 | |
| VIEYTRAGKPEPSET | 1411 | Q86TB3 | |
| SQRSDPIFLDVKYGP | 146 | Q6UY09 | |
| EEPTFIDPEAIKYFR | 261 | Q6UXU4 | |
| AVPSTFYSQREKPGI | 1091 | Q8TCU4 | |
| GEYEPKIEVQFPETV | 221 | Q8IWV2 | |
| DRQPPISVYNTAGEK | 1056 | O95342 | |
| GTIEKVYPEPRSESE | 51 | Q14155 | |
| NAPQPIFKGRSYEED | 976 | O60306 | |
| VYGPDSEATTRPKEN | 516 | O60423 | |
| IKETDYNGFPVVVSR | 626 | P51793 | |
| KETEIFFQPSQGYRP | 871 | Q8TDJ6 | |
| RFPVDIFYTKAPEAD | 576 | O60231 | |
| DQPPRFTKAEYTAGV | 2841 | Q9H251 | |
| RYLKGENPFTDSPEE | 541 | Q9ULX6 | |
| SKQRYPSQPRGDTVD | 711 | P54802 | |
| TGEASKLPYDVTPEQ | 1106 | P46940 | |
| DPVSEYKRQGLPNES | 231 | Q13613 | |
| AYAEFLQPAKERPET | 721 | Q7Z5L2 | |
| EYQARIPEFDPGATK | 6 | Q9P2K3 | |
| VKEEGSPDSYELSPQ | 171 | P13631 | |
| TDAPDKGYVVPNVDL | 71 | Q96B26 | |
| YDQEAGTEKSVFPLP | 1236 | Q68DA7 | |
| EFPEERKTLQIDGPY | 351 | Q9H8X2 | |
| PEYNVTIVATDRGKP | 416 | Q9Y5F9 | |
| PEYNVTIAATDRGKP | 416 | Q9Y5F8 | |
| TIFSLYKEDGVPVPE | 56 | Q8N109 | |
| FDPYSDDPRLGVQKV | 506 | Q15334 | |
| VNDSPPRFTAEIYKG | 2911 | Q14517 | |
| EAYFAVQPRPSSEKI | 371 | Q01851 | |
| YQKETESAPGSPRAV | 511 | Q6PKG0 | |
| QPGDPLKRSSFIIYD | 381 | Q96EY7 | |
| PAAEEYGYIVTDQKP | 466 | Q16849 | |
| FDPYSDDPRLGIQKI | 496 | Q6P1M3 | |
| GKEETQYERTEPSPN | 216 | Q6ZWT7 | |
| KTGTPVEPEYFEQVT | 866 | Q02846 | |
| PGSDFVYVVDTRPKL | 231 | Q9Y216 | |
| PAVETPYLARAGKNE | 1671 | O60333 | |
| TQPYPAFTRGVEDDV | 2221 | O43451 | |
| GPLEQRKFISEAQPY | 171 | Q96Q04 | |
| QDGDYREFPIPEQFK | 446 | P40123 | |
| TIFSLYKEDGVPVPE | 56 | Q8NHK3 | |
| PTKPGEYFVNILFEE | 1101 | O75369 | |
| GVDPFSYRPKQENLE | 161 | P23409 | |
| IKQEPRDFAYDSEVP | 256 | P50549 | |
| KGPRQFYDDTCVVPE | 296 | P50549 | |
| VESVFKNYDPEGRGT | 471 | Q8TDF6 | |
| PETSPYVKEFRDGCQ | 1676 | P13942 | |
| ANPVYSGAVFEPERK | 396 | Q96BD5 | |
| LPKPVVVETFFGYDE | 446 | Q5VZ66 | |
| PRSADPRSNYGVVEK | 551 | Q6ZU52 | |
| DNRTFSYPGVVKTPV | 996 | P48552 | |
| GRPPYAASAEEVAKE | 1016 | Q9NZB2 | |
| SPEDIPSDKQRFYTN | 301 | Q13568 | |
| KAFGDFVINRPDTPY | 786 | Q68DD2 | |
| FGTEQPPKYEDVVQL | 326 | Q06190 | |
| AFSREPDNPKTYVQD | 1076 | P29474 | |
| DRADIKQYIGPPSAA | 311 | Q15645 | |
| YEDVPEDSPIGTVKA | 886 | Q6V1P9 | |
| KGVDQYPAVVSLPSD | 341 | Q96MD2 | |
| DDKVQSTYFLTRPEP | 386 | Q96MD2 | |
| QADSPPIIVGEEYSK | 246 | Q8N6M0 | |
| SVRSREGKEFAPVYP | 811 | Q9UP83 | |
| QEGEPPTVEARYKSF | 296 | P87889 | |
| NTVRQGSKEPYPDFV | 441 | P87889 | |
| GSKEPYPDFVARLQD | 446 | P87889 | |
| QEGEPPTVEARYKSF | 296 | Q9YNA8 | |
| NTVRQGSKEPYPDFV | 441 | Q9YNA8 | |
| GSKEPYPDFVARLQD | 446 | Q9YNA8 | |
| QEGEPPTVEARYKSF | 296 | P62683 | |
| SSKEPYPDFVARLQD | 446 | P62683 | |
| QEGEPPTVEARYKSF | 296 | P63145 | |
| NTVRQGSKEPYPDFV | 441 | P63145 | |
| GSKEPYPDFVARLQD | 446 | P63145 | |
| SIRQGSKEPYPDFVA | 441 | Q9HDB9 | |
| QEGEPPTVEARYKSF | 296 | Q7LDI9 | |
| NTVRQGSKEPYPDFV | 441 | Q7LDI9 | |
| GSKEPYPDFVARLQD | 446 | Q7LDI9 | |
| QEGEPPTVEARYKSF | 296 | P63130 | |
| NTVRQGSKEPYPDFV | 441 | P63130 | |
| GSKEPYPDFVARLQD | 446 | P63130 | |
| QEGEPPTVEARYKSF | 296 | P62685 | |
| NTVRQGSKEPYPDFV | 441 | P62685 | |
| GSKEPYPDFVARLQD | 446 | P62685 | |
| QEGEPPTVEARYKSF | 296 | P63126 | |
| NTVRQGSKEPYPDFV | 441 | P63126 | |
| GSKEPYPDFVARLQD | 446 | P63126 | |
| QEGEPPTVEARYKSF | 296 | P62684 | |
| NTVRQGSKEPYPDFV | 441 | P62684 | |
| GSKEPYPDFVARLQD | 446 | P62684 | |
| ESVIEEPYQKSEQGP | 641 | A4FU69 | |
| SYGAPRGDKEELTPQ | 211 | P24001 | |
| KFLTENVSGTPEYPD | 111 | Q8TE85 | |
| DRDYKPQVGVIADPS | 2601 | Q99715 | |
| NTKPDGPITREEFRY | 416 | Q5THR3 | |
| NAVVRYFGESPKTTP | 896 | Q8IVF7 | |
| SFPPYATQEAEKREF | 956 | Q8N3K9 | |
| REVSPAYTQFLEDPG | 471 | Q8IYE1 | |
| SVEKPGEPRAVVYEA | 1161 | Q8N1P7 | |
| LSPGEDAVYFKINPR | 411 | Q8TDW7 | |
| IASVYVRGQEPAPDK | 36 | Q6P9A2 | |
| QGPDRPQEVSYTDTK | 46 | P49841 | |
| EKPTADAEAYVFTPN | 601 | P09871 | |
| SDGFPVYQEKIIRES | 256 | Q8IV38 | |
| QKTDTRENPQEYPDF | 931 | Q9P203 | |
| QKGIPVETDSEEQPY | 366 | Q14790 | |
| PYTEPEEDFGDTKRI | 321 | Q96L34 | |
| GRPEDPQKVFSYSER | 1266 | Q9ULL0 | |
| IVTPPVDKEAESYQG | 196 | Q92851 | |
| RIEGSNKVPVDPATY | 451 | P06396 | |
| EVGSLAEVKENPPFY | 471 | Q9NQC7 | |
| YLKNEVEEGVSPSQP | 511 | O60645 | |
| VKEVPEEYSERFSPQ | 401 | P43250 | |
| EYILVPSTFEPNKDG | 481 | P17655 | |
| PYKERAPQFQESVGS | 1166 | Q5VT52 | |
| QDDVSPYFKTEPVRT | 21 | Q58EX2 | |
| PGHRTFETKDQPEYD | 201 | B1AKI9 | |
| EISGEITYPPQKADA | 21 | P0DN24 | |
| KRQVGDYENVIPDFP | 801 | P20273 | |
| TPYEKGIEVDPSISR | 516 | O15259 | |
| EEGVNKFSYPPSHRE | 171 | O75807 | |
| PEFDYRPESEKVIQT | 601 | Q5THK1 | |
| YGQLDFPVRDEKEPN | 2706 | Q5T011 | |
| QDQDYRTGPSEEKPS | 441 | P78332 | |
| NPESPTEEKIREYFG | 161 | Q99729 | |
| TPKTSEEAVDPLGNY | 111 | Q96R06 | |
| ETIFPDAKELDGPVY | 691 | Q7Z6B7 | |
| ASYGPFSVEKIIPQE | 86 | Q14DG7 | |
| SPVSIFVYDVKPGAE | 41 | Q96KG9 | |
| SSKDERQEDPYGPQT | 66 | O15226 | |
| PQRDPEIYTDPEVFK | 391 | Q16647 | |
| AKRGITIYADPDVPE | 331 | Q587J7 | |
| ARDDYKTLVGSENPP | 766 | Q13576 | |
| KDPEAPIFQVADYGI | 301 | P13804 | |
| QIPGDKYQVFDSAPR | 531 | Q8N5V2 | |
| VASQSYRPLEVPDGK | 86 | Q7Z5V6 | |
| KNSVPASDDGYPEIE | 101 | Q9NZH4 | |
| GPFRDVPAYSQDTFK | 201 | P04843 | |
| PKASYGEIRIPEENS | 276 | Q86V20 | |
| EVKDYEPPFGSKVRE | 466 | P37173 | |
| SVQGLPAFRYKVPAE | 286 | Q14108 | |
| RKCFSIDNPGYEPEV | 436 | O75083 | |
| DVPAGTYPRKFNETQ | 731 | Q13017 | |
| ATAEVPYPDDLVGFK | 891 | Q15477 | |
| FPAKEIPANGTDIVY | 211 | Q15198 | |
| VNKEYPGLADPVFRT | 846 | Q9Y4F9 | |
| QEGEPPTVEARYKSF | 296 | P63128 | |
| NTVRQGSKEPYPDFV | 441 | P63128 | |
| GSKEPYPDFVARLQD | 446 | P63128 | |
| DVVPFQESPKYAARR | 406 | Q9Y566 | |
| ESPDFQPSIAKRYID | 171 | Q15172 | |
| LYSPRGEEITTKPEN | 106 | O15204 | |
| PQDTADKDAVYGVPF | 51 | Q6ZVT6 | |
| PNYEISEGKPRAISA | 56 | Q5K130 | |
| EKRPYGEFERQQTEG | 21 | Q9BRU2 | |
| RTDRTNKFYEGPENP | 381 | Q9HA65 | |
| AGTVVPETNKEPRYQ | 466 | Q9UDY2 | |
| VYGDFEPLVAKERSP | 66 | Q5JTV8 | |
| PGTKVYEVVNEDPET | 601 | Q9Y5T5 | |
| EQFYVTREKGTEPPF | 61 | Q9Y3D2 | |
| DEPNSTPEKTEQFYR | 101 | O76021 | |
| TTRDYEGPAIAPKVQ | 671 | O15066 | |
| HPKDIRESDYFTPQG | 686 | Q8TCJ2 | |
| EDVNPPKEDYGSSKR | 126 | Q5TCZ1 | |
| EITPGPATYEISQEK | 431 | Q8N412 | |
| TEEQQPGKEGPRVIY | 366 | Q86VE9 | |
| YKDRDGQPQVVPVAA | 1611 | P22105 | |
| EQEFPVEPVGEKSNY | 1241 | O75116 | |
| KEQRGEPETFLPLDY | 561 | Q14683 | |
| ERFVASNPSKVSYEP | 1871 | Q9UQD0 | |
| PAIFYRPKGREEESD | 981 | Q92620 | |
| GPENKPVSVQETYEA | 336 | Q9P0V9 | |
| PDIYQIAKSEPRDAG | 666 | Q07157 | |
| TLTKNYEDERPDIPF | 1326 | Q8N9V7 | |
| FDAPLGYKEPERQVQ | 191 | Q92890 | |
| KEAPPEIISQGYNFE | 91 | Q8TBZ5 | |
| HREVDEDFPRGPKTY | 466 | Q8N3Z6 | |
| GRPPFETTNLKETYR | 276 | Q9NYY3 | |
| EEKPRYLGPVTFEDV | 26 | Q86UQ0 | |
| FPEGTRYNPEQTKVL | 171 | Q9NUQ2 | |
| EEQSTGPIKYAFQPE | 1306 | O60293 | |
| AQPKGDPRIEYQFFE | 956 | Q9NYU2 | |
| EKSRTYVARNGEPEP | 111 | P40222 | |
| EGVKTLPNETFTDYP | 411 | Q9HCX4 | |
| KDPDERPTFEYIQSF | 511 | P07947 | |
| PGFETLELKENTDYP | 821 | Q7Z570 | |
| GPSAQGKPTYFREEE | 181 | Q9H9Z2 | |
| NSYTPIDDFEKRVTP | 1671 | Q9NQX4 | |
| EQRAPKSVTDYDFAP | 1136 | Q9UM54 | |
| FFEVKQTSEPSYPDV | 2011 | Q6PIF6 | |
| TPFDFTPENYKRIEA | 51 | P19404 | |
| EYEEDRGKGFFPQTI | 461 | P20929 | |
| DILNGKPYEPEFTSD | 786 | P19838 |